Literature DB >> 34319350

Überantibodies From Recovered COVID-19 Patients Could Spur New Therapeutics and Vaccines.

Jennifer Abbasi.   

Abstract

Entities:  

Year:  2021        PMID: 34319350     DOI: 10.1001/jama.2021.12915

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  1 in total

1.  Characterization of pathogen-inactivated COVID-19 convalescent plasma and responses in transfused patients.

Authors:  Maja Weisser; Nina Khanna; Anemone Hedstueck; Sarah Tschudin Sutter; Sandra Roesch; Gregor Stehle; Mihaela Sava; Nikolaus Deigendesch; Manuel Battegay; Laura Infanti; Andreas Holbro; Stefano Bassetti; Hans Pargger; Hans H Hirsch; Karoline Leuzinger; Laurent Kaiser; Diem-Lan Vu; Katharina Baur; Nadine Massaro; Michael Paul Busch; Graham Simmons; Mars Stone; Philip L Felgner; Rafael R de Assis; Saahir Khan; Cheng-Ting Tsai; Peter V Robinson; David Seftel; Johannes Irsch; Anil Bagri; Andreas S Buser; Laurence Corash
Journal:  Transfusion       Date:  2022-09-05       Impact factor: 3.337

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.